Market Overview:
The global companion animal specialty drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of companion animals, rising awareness about pet health and growing demand for advanced veterinary care. Companion animal specialty drugs are used for the treatment of various diseases and disorders in pets such as dogs, cats, horses, and other animals. These drugs are available in different forms such as tablets, capsules, ointments/creams/gels, liquids/syrups, injections/shots and others (including topicals). The global companion animal specialty drugs market is segmented on the basis of type into antibiotics, anti-inflammatory drugs Parasiticides heartworm nutritional products anti-obesity drugs skin care products vaccines among others. The antibiotics segment is expected to account for the largest share of the global companion animal specialty drug market in 2018 owing to their high usage rates for treating various infections in pets. However; overuse or misuse of these medications can lead to antibiotic resistance which is a major concern globally.
Product Definition:
Companion Animal Speciality Drugs are drugs that are used to treat diseases or conditions in companion animals. These drugs can be used to treat a wide variety of conditions, including cancer, heart disease, and arthritis. The importance of Companion Animal Speciality Drugs is that they can help improve the quality of life for companion animals and help them live longer, healthier lives.
Antibiotics:
Antibiotics are types of antimicrobials used in the treatment and prevention of bacterial infections. They can be administered topically, orally or intravenously. Bacterial infection is treated with antibiotics when it cannot be treated with antifungal medication or when the body's immune system fails to function properly.
Anti-inflammatory Drugs:
Anti-inflammatory drugs are used to reduce the inflammation of any body part or organ. The most common symptoms that cause inflammation are redness, swelling, and heat in the area of injury. Some other symptoms include cough, fever, diarrhea or weight loss. There are different types of anti-inflammatory drugs available in the market for animals as well as people which differ according to their type and action on the immune system.
Application Insights:
The companion animal specialty drugs market is segmented based on application into hospital, clinic and others. The hospital segment dominated the market in 2017 due to high usage of these drugs by hospitals for treatment of various diseases in pets. Companion animals require regular visits to the veterinarian for check-ups and routine vaccines, which encourages people to opt for veterinary healthcare services at clinics or hospitals over other options such as online or offline pet stores. This factor along with increasing government initiatives towards improving pet health care is expected to drive demand over the forecast period.
The others segment includes mail order pharmacies, retail pharmacies and pharmacy internet sites that sell medicines directly to customers through online prescriptions without having face-to-face contact with them first like chat rooms or phone lines do.
Regional Analysis:
North America dominated the global companion animal specialty drugs market in 2017. This can be attributed to rising pet ownership, increasing awareness about veterinary healthcare facilities and availability of advanced treatment options for pets at low cost. Moreover, high R&D investment by companies for the development of novel drugs is one of the key factors contributing to its largest share.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to growing disposable income levels and a rise in consumer awareness towards veterinary health issues associated with common diseases in this region. In addition, an increase in pet adoption along with government initiatives such as “One Health†policy implemented by China CDC will also boost regional growth during the forecast period. The One Health Policy was introduced as a part of efforts undertaken by Chinese Government aimed at promoting better animal husbandry practices across China thus leading towards improved human health outcomes from livestock exposure through disease transmission pathways (Xinhua 2013).
Growth Factors:
- Increasing demand for companion animals from developed countries
- Rising awareness about the benefits of companion animal ownership among people
- Growing number of veterinary clinics and hospitals offering specialized services for companion animals
- Proliferation of pet-friendly policies and regulations by government authorities in developed countries
- Technological advancements in the field of veterinary medicine that are resulting in better diagnosis and treatment options for companion animals
Scope Of The Report
Report Attributes
Report Details
Report Title
Companion Animal Speciality Drugs Market Research Report
By Type
Antibiotics, Anti-inflammatory Drugs, Parasiticides, Heartworm, Nutritional Products, Anti-Obesity Drugs, Skin Care Products, Vaccines
By Application
Hospital, Clinic, Others
By Companies
Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale, Zoetis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
226
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Companion Animal Speciality Drugs Market Report Segments:
The global Companion Animal Speciality Drugs market is segmented on the basis of:
Types
Antibiotics, Anti-inflammatory Drugs, Parasiticides, Heartworm, Nutritional Products, Anti-Obesity Drugs, Skin Care Products, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Merck
- Bayer
- Elanco
- Boehringer Ingelheim
- Ceva Sante Animale
- Zoetis
Highlights of The Companion Animal Speciality Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Anti-inflammatory Drugs
- Parasiticides
- Heartworm
- Nutritional Products
- Anti-Obesity Drugs
- Skin Care Products
- Vaccines
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Companion Animal Speciality Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Companion Animal Specialty Drugs are medications specifically designed for use in companion animals. These drugs may be prescribed by veterinarians, or they may be available over the counter. Companion Animal Specialty Drugs can help to treat a variety of conditions, including allergies, arthritis, cancer, and more.
Some of the major players in the companion animal speciality drugs market are Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale, Zoetis.
The companion animal speciality drugs market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Speciality Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Speciality Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Speciality Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Speciality Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Speciality Drugs Market Size & Forecast, 2020-2028
4.5.1 Companion Animal Speciality Drugs Market Size and Y-o-Y Growth
4.5.2 Companion Animal Speciality Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Anti-inflammatory Drugs
5.2.3 Parasiticides
5.2.4 Heartworm
5.2.5 Nutritional Products
5.2.6 Anti-Obesity Drugs
5.2.7 Skin Care Products
5.2.8 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Companion Animal Speciality Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Companion Animal Speciality Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Anti-inflammatory Drugs
9.6.3 Parasiticides
9.6.4 Heartworm
9.6.5 Nutritional Products
9.6.6 Anti-Obesity Drugs
9.6.7 Skin Care Products
9.6.8 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Anti-inflammatory Drugs
10.6.3 Parasiticides
10.6.4 Heartworm
10.6.5 Nutritional Products
10.6.6 Anti-Obesity Drugs
10.6.7 Skin Care Products
10.6.8 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Anti-inflammatory Drugs
11.6.3 Parasiticides
11.6.4 Heartworm
11.6.5 Nutritional Products
11.6.6 Anti-Obesity Drugs
11.6.7 Skin Care Products
11.6.8 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Anti-inflammatory Drugs
12.6.3 Parasiticides
12.6.4 Heartworm
12.6.5 Nutritional Products
12.6.6 Anti-Obesity Drugs
12.6.7 Skin Care Products
12.6.8 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Anti-inflammatory Drugs
13.6.3 Parasiticides
13.6.4 Heartworm
13.6.5 Nutritional Products
13.6.6 Anti-Obesity Drugs
13.6.7 Skin Care Products
13.6.8 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Companion Animal Speciality Drugs Market: Competitive Dashboard
14.2 Global Companion Animal Speciality Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Merck
14.3.3 Bayer
14.3.4 Elanco
14.3.5 Boehringer Ingelheim
14.3.6 Ceva Sante Animale
14.3.7 Zoetis
